New Phase 3 Data for Tradjenta ® (linagliptin) Tablets
May 24, 2012 (Boehringer Ingelheim) — New Phase 3 data for Tradjenta ® (linagliptin) tablets in black or African American patients with type 2 diabetes showed significant improvement in blood sugar. First published trial of a dipeptidyl peptidase-4 (DPP-4) inhibitor specifically conducted in black or African American patients with type 2 diabetes.
read more (Source: Diabetes News from dLife.com)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div
Calcium Supplements May Increase Heart Attack Risk
An analysis of data on nearly 24,000 people followed for over a decade suggests taking calcium supplements may increase the risk of having a heart attack. This is the main finding of a study published online this week in the journal Heart that also concludes boosting overall calcium intake through dietary sources brings no significant benefit in terms of reducing risk of heart disease or stroke. The researchers say calcium supplements, which are often recommended to the elderly and women after the menopause to protect against bone thinning, should be taken with caution... (Source: Health News from Medical News Today)
